|
1
|
10
|
4udaB |
Mr in complex with dexamethasone |
|
1
|
9
|
4tuzF |
Crystal structure of hera-lbd (y537s) in complex with alpha-zearalenol |
|
42
|
112
|
4ts8A |
Crystal structure of the bromodomain of human crebbp in complex with xz08 |
|
2
|
12
|
4udbB |
Mr in complex with desisobutyrylciclesonide |
|
10
|
71
|
4qqgA |
Crystal structure of an n-terminal htatip fragment |
|
2
|
10
|
4rujB |
Crystal structure of zvdr l337h mutant-vd complex |
|
113
|
501
|
4rgwA |
Crystal structure of a taf1-taf7 complex in human transcription factor iid |
|
2
|
10
|
4rupB |
Crystal structure of zvdr l337h mutant-gemini72 complex |
|
117
|
378
|
4pzrA |
Crystal structure of p300 histone acetyltransferase domain in complex with coenzyme a |
|
118
|
378
|
4pzsA |
Crystal structure of p300 histone acetyltransferase domain in complex with acetyl-coenzyme a |
|
98
|
313
|
4psxA |
Crystal structure of histone acetyltransferase complex |
|
112
|
378
|
4pztA |
Crystal structure of p300 histone acetyltransferase domain in complex with an inhibitor, acetonyl-coenzyme a |
|
105
|
493
|
4oy2A |
Crystal structure of taf1-taf7, a tfiid subcomplex |
|
101
|
316
|
4pswA |
Crystal structure of histone acetyltransferase complex |
|
38
|
114
|
4oufA |
Crystal structure of cbp bromodomain |
|
41
|
116
|
4nr7A |
Crystal structure of the bromodomain of human crebbp in complex with an isoxazolyl-benzimidazole ligand |
|
55
|
231
|
4n3wA |
Crystal structure of the bromodomain-phd finger module of human transcriptional co-activator cbp in complex with acetylated histone 4 peptide (h4k20ac). |
|
42
|
113
|
4nr4A |
Crystal structure of the bromodomain of human crebbp in complex with an isoxazolyl-benzimidazole ligand |
|
42
|
161
|
4nsqA |
Crystal structure of pcaf |
|
55
|
232
|
4n4fA |
Crystal structure of the bromodomain-phd finger module of human transcriptional co-activator cbp in complex with di-acetylated histone 4 peptide (h412ack16ac). |
|
42
|
116
|
4nyxA |
Crystal structure of the bromodomain of human crebbp in complex with a dihydroquinoxalinone ligand |
|
37
|
113
|
4nr5A |
Crystal structure of the bromodomain of human crebbp in complex with an isoxazolyl-benzimidazole ligand |
|
41
|
116
|
4nywA |
Crystal structure of the bromodomain of human crebbp in complex with a dihydroquinoxalinone ligand |
|
42
|
116
|
4nyvA |
Crystal structure of the bromodomain of human crebbp in complex with a quinazolin-one ligand |
|
42
|
116
|
4nr6A |
Crystal structure of the bromodomain of human crebbp in complex with an oxazepin ligand |
|
2
|
9
|
4mg5C |
Crystal structure of hera-lbd (y537s) in complex with chlordecone |
|
29
|
123
|
4llbA |
Crystal structure of moz double phd finger histone h3k14ac complex |
|
1
|
9
|
4mg9F |
Crystal structure of hera-lbd (y537s) in complex with butylparaben |
|
2
|
9
|
4mgaC |
Crystal structure of hera-lbd (y537s) in complex with 4-tert-octylphenol |
|
1
|
9
|
4mgcF |
Crystal structure of hera-lbd (y537s) in complex with benzophenone-2 |
|
2
|
10
|
4mg8C |
Crystal structure of hera-lbd (y537s) in complex with alpha-zearalanol |
|
28
|
126
|
4lkaA |
Crystal structure of moz double phd finger histone h3k9ac complex |
|
2
|
9
|
4mg6C |
Crystal structure of hera-lbd (y537s) in complex with benzylbutylphtalate |
|
1
|
9
|
4mgbC |
Crystal structure of hera-lbd (y537s) in complex with tcbpa |
|
2
|
9
|
4mg7C |
Crystal structure of hera-lbd (y537s) in complex with ferutinine |
|
1
|
9
|
4mgdF |
Crystal structure of hera-lbd (y537s) in complex with hpte |
|
28
|
126
|
4lk9A |
Crystal structure of moz double phd finger histone h3 tail complex |
|
24
|
124
|
4ljnA |
Crystal structure of moz double phd finger |
|
102
|
321
|
4j5wA |
Crystal structure of the apo-pxr/rxralpha lbd heterotetramer complex |
|
2
|
11
|
4jygF |
Crystal structure of rarbeta lbd in complex with agonist bms411 [4-{[(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl)carbonyl]amino}benzoic acid] |
|
25
|
78
|
4i9oA |
Crystal structure of gackix l664c tethered to 1-10 |
|
3
|
10
|
4jyhC |
Crystal structure of rarbeta lbd in complex with selective agonist bms948 [4-{[(8-phenylnaphthalen-2-yl)carbonyl]amino}benzoic acid] |
|
78
|
260
|
4j5wC |
Crystal structure of the apo-pxr/rxralpha lbd heterotetramer complex |
|
2
|
9
|
4jyiF |
Crystal structure of rarbeta lbd in complex with selective partial agonist bms641 [3-chloro-4-[(e)-2-(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl)ethenyl]benzoic acid] |
|
99
|
318
|
4j5xA |
Crystal structure of the sr12813-bound pxr/rxralpha lbd heterotetramer complex |
|
81
|
259
|
4j5xC |
Crystal structure of the sr12813-bound pxr/rxralpha lbd heterotetramer complex |
|
4
|
16
|
4heeY |
Crystal structure of ppargamma in complex with compound 13 |
|
2
|
10
|
4g20B |
Structural basis for the accommodation of bis- and tris-aromatic derivatives in vitamin d nuclear receptor |
|
2
|
10
|
4g2hB |
Structural basis for the accommodation of bis- and tris-aromatic derivatives in vitamin d nuclear receptor |
|
2
|
11
|
4g1dB |
Structural basis for the accommodation of bis- and tris-aromatic derivatives in vitamin d nuclear receptor |
